Lindroos P M, Coin P G, Badgett A, Morgan D L, Bonner J C
Laboratory of Pulmonary Pathobiology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA.
Am J Respir Cell Mol Biol. 1997 Mar;16(3):283-92. doi: 10.1165/ajrcmb.16.3.9070613.
Enhanced proliferation of fibroblasts is a primary characteristic of lung fibrosis. Macrophage-secreted platelet-derived growth factor (PDGF) is a potent mitogen and chemoattractant for lung fibroblasts. The magnitude of the fibroblast PDGF response is dependent on the number of PDGF receptor alpha (PDGF-R alpha) relative to PDGF-R beta at the cell surface. We recently reported that upregulation of the PDGF-R alpha subtype by interleukin (IL)-1beta results in enhanced lung fibroblast proliferation in response to PDGF-AA, PDGF-AB, and PDGF-BB whereas transforming growth factor (TGF)-beta1 has the opposite effect. Both IL-1beta and TGF-beta1 are produced by particle-activated macrophages in vivo and in vitro. We studied the net effect of macrophage conditioned medium (MOCM), which contains both IL-1beta and TGF-beta1, on the expression of the lung fibroblast PDGF receptor system. MOCM obtained from unstimulated, titanium dioxide (TiO2)-, chrysotile asbestos-, or residual oil fly ash (ROFA)-exposed macrophages in vitro increased [125I]PDGF-AA binding 3-, 6-, 6-, and 20-fold, respectively. These increases correlated with increased PDGF-R alpha mRNA and protein expression as shown by northern and western assays. PDGF-AB and -BB-stimulated [3H]thymidine incorporation by fibroblasts was enhanced 5-, 5-, 10-, and 20-fold by pretreatment with MOCM from unstimulated, TiO2-, asbestos-, and ROFA-exposed macrophages, respectively. [125I]PDGF-AA binding experiments using the IL-1 receptor antagonist blocked the upregulatory effect of all MOCM samples. Latent TGF-beta1 present in MOCM was activated by acid treatment, inhibiting upregulation by approximately 60%, a result similar to experiments with IL-1beta and TGF-beta1 mixtures. Treatment with a TGF-beta neutralizing antibody restored full upregulatory activity to acidified MOCM. Thus activated macrophages increase lung fibroblast PDGF-R alpha primarily due to the secretion of IL-1beta. Intratracheal instillation of ROFA particles in rats induced a 2-fold increase in total lung PDGF-R alpha mRNA in vivo. These findings support the idea that macrophage-derived IL-1beta plays a key role in the initiation of a fibrotic response by increasing fibroblast PDGF-R alpha expression, thereby dramatically potentiating the mitogenic response to PDGF.
成纤维细胞增殖增强是肺纤维化的主要特征。巨噬细胞分泌的血小板衍生生长因子(PDGF)是一种强效的有丝分裂原和肺成纤维细胞趋化因子。成纤维细胞对PDGF的反应强度取决于细胞表面PDGF受体α(PDGF-Rα)相对于PDGF-Rβ的数量。我们最近报道,白细胞介素(IL)-1β上调PDGF-Rα亚型会导致肺成纤维细胞对PDGF-AA、PDGF-AB和PDGF-BB的增殖增强,而转化生长因子(TGF)-β1则有相反的作用。IL-1β和TGF-β1在体内和体外均由颗粒激活的巨噬细胞产生。我们研究了含有IL-1β和TGF-β1的巨噬细胞条件培养基(MOCM)对肺成纤维细胞PDGF受体系统表达的净效应。从未刺激的、暴露于二氧化钛(TiO2)、温石棉或残油飞灰(ROFA)的巨噬细胞体外获得的MOCM分别使[125I]PDGF-AA结合增加3倍、6倍、6倍和20倍。如Northern和Western分析所示,这些增加与PDGF-Rα mRNA和蛋白表达增加相关。用未刺激的、暴露于TiO2、石棉和ROFA的巨噬细胞的MOCM预处理分别使成纤维细胞受PDGF-AB和-BB刺激的[3H]胸腺嘧啶核苷掺入增加5倍、5倍、10倍和20倍。使用IL-1受体拮抗剂的[125I]PDGF-AA结合实验阻断了所有MOCM样品的上调作用。MOCM中存在的潜伏TGF-β1经酸处理后被激活,上调作用抑制约60%,这一结果与IL-1β和TGF-β1混合物的实验相似。用TGF-β中和抗体处理可使酸化的MOCM恢复完全上调活性。因此,活化的巨噬细胞主要通过分泌IL-1β增加肺成纤维细胞PDGF-Rα。在大鼠气管内滴注ROFA颗粒可使体内肺总PDGF-Rα mRNA增加2倍。这些发现支持这样一种观点,即巨噬细胞衍生的IL-1β通过增加成纤维细胞PDGF-Rα表达在纤维化反应的起始中起关键作用,从而显著增强对PDGF的促有丝分裂反应。